SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-22-117516
Filing Date
2022-04-25
Accepted
2022-04-25 16:03:01
Documents
9
Period of Report
2022-06-09

Document Format Files

Seq Description Document Type Size
1 DEF 14A d317669ddef14a.htm DEF 14A 936321
2 GRAPHIC g317669g01g02.jpg GRAPHIC 56899
3 GRAPHIC g317669g01g39.jpg GRAPHIC 198288
4 GRAPHIC g317669g22m58.jpg GRAPHIC 53999
5 GRAPHIC g317669snap0001.jpg GRAPHIC 1770
6 GRAPHIC g317669snap0003.jpg GRAPHIC 803
7 GRAPHIC g317669snap0005.jpg GRAPHIC 725
8 GRAPHIC g317669snap0006.jpg GRAPHIC 805
9 GRAPHIC g317669snap0007.jpg GRAPHIC 814
  Complete submission text file 0001193125-22-117516.txt   1371173
Mailing Address 12278 SCRIPPS SUMMIT DRIVE SAN DIEGO CA 92131
Business Address 12278 SCRIPPS SUMMIT DRIVE SAN DIEGO CA 92131 858.875.1803
FATE THERAPEUTICS INC (Filer) CIK: 0001434316 (see all company filings)

IRS No.: 651311552 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36076 | Film No.: 22849680
SIC: 2836 Biological Products, (No Diagnostic Substances)